Results 241 to 250 of about 7,990,092 (312)

From energy provision to protein synthesis: Tunnelling nanotubes as mediators of intercellular metabolic cooperation in cancer

FEBS Open Bio, EarlyView.
The cytoskeleton‐mediated transport of mitochondria via tunnelling nanotubes restores respiration, increases ATP production, rescues cells from apoptosis, activates the AKT/mTOR signalling pathway, promotes cell migration and invasiveness, contributes to cancer progression and treatment resistance.
Stanislava Martínková, Jan Trnka
wiley   +1 more source

The global landscape of pediatric monoclonal antibody (mAb) clinical trials: an analysis of ClinicalTrials.gov. [PDF]

Front Pediatr
Sharma A, Mukherjee S, Lynch S.
europepmc   +1 more source

Leveraging Synthetic Clinical Data for Validation and Operational Readiness in Clinical Trials. [PDF]

Healthcare (Basel)
Musik S, Zalewski J, Jurkowska J, Pędzimąż W, Sasin-Kurowska J, Panczyk M.   +5 more
europepmc   +1 more source

Automatic prediction of patients early discontinuation in oncology clinical trials. [PDF]

ESMO Real World Data Digit Oncol
Olgiati L, Filori Q, Toueress S, Brutti-Mairesse C, Zidane L, Ikhlef N, Gueguen L, Verlingue L.   +7 more
europepmc   +1 more source

Defining Heart Failure Endpoint in ATTR Amyloidosis Clinical Trials: Time for an Update? [PDF]

Cardiol Ther
Gjermeni D, Alexander KM, Januzzi JL, Mahaffey KW.   +3 more
europepmc   +1 more source

Partnering with patients and the public in the clinical trials ecosystem: a decade of lessons learned and shared. [PDF]

BMJ Open
Richards DP, Fink C, Granieri M, Kobow K, Lane T, Lillie D, Mitchell K, Munro C, Smith M, Walz M, Marlin S.   +10 more
europepmc   +1 more source

Intravenous Everolimus Formulation (Sapu003) for Clinical Trials. [PDF]

Int J Mol Sci
Min SH, Forero K, Putnam W, Anderson J, Hoff R, Lopp J, Trieu V, Ho K, Lee C.   +8 more
europepmc   +1 more source